Unlimited Viewing Recorded Version for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Call : +1-800-385-1627
Mailto : support@recordedwebinars.com
Overview:
This webinar is intended for Pet Food Industry Representatives, Manufacturers, Regulatory Affairs Professionals, Managers, Consultants, Scientists, Research Analysts, Market Watchers, and Investment Analysts seeking an understanding of how pet food is regulated in the United States.
Pet food is regulated by the U.S. Food and Drug Administration ("FDA") under the Federal Food, Drug, and Cosmetic Act ("FDCA") which defines food as "articles used for food or drink for man or other animals, chewing gum, and articles used for components of any such article." Thus, pet food squarely falls under FDA's regulatory jurisdiction. In addition to FDA, pet food is also regulated by the various individual states to some extent.
This webinar will focus on FDA rules governing product development and formulation, manufacturing, facility inspections, labeling and promotion, and recalls. Considerable attention will also be devoted to a discussion of the recently enacted Food Safety Modernization Act ("FSMA") and where the FDA is in the process of implementing its requirements and publishing-related guidance documents.
The presenter will also provide an overview of recent regulatory trends and potential enforcement risks in the market today. This will include an introduction to several safety issues impacting the industry that have come up over the last few years including problems with Chicken Jerky Treats and the widespread contamination of pet food with melamine.
Why you should Attend:
Areas Covered in the Session:
Who Will Benefit:
Karl Nobert , FDA Regulatory Attorney, Michael Best & Friedrich LLP. Karl focuses his practice on FDA Regulatory law, representing the U.S. and international clients in food.
and drug industries with regard to pharmaceuticals and biologics, medical devices, and veterinary products. He has particular experience and professional interest in the areas of prescription drugs, regenerative medicine, and animal health. In addition to practicing law, Karl founded a veterinary drug company that is pursuing approval for an equine cell-based respiratory drug.